miR-592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin-dependent kinase 8.

The authors confirm that there are no further errors in the study, and all the authors agree to this correction. Mol Med Rep 22: 3316-3326, 2020, DOI: 10.3892/mmr.2020.11392 Following the publication of this paper, the authors have realized that they overlooked indicating that Ting Liu and Jingjing Meng contributed equally to this work. [Extracted from the article]